Nektar Therapeutics (NasdaqCM:NKTR) Update / briefing Transcript

Nektar Therapeutics (NasdaqCM:NKTR) Update / briefing February 10, 2026 08:00 AM ET Company ParticipantsDavid Rosmarin - Chairman and Professor of DermatologyGil Labrucherie - CFOHoward W. Robin - President and CEOJonathan Silverberg - Professor of DermatologyJonathan Zalevsky - Chief Research and Development OfficerMary Tagliaferri - Chief Medical OfficerVivian Wu - VP of Investor Relations and Corporate AffairsNone - Company RepresentativeConference Call ParticipantsArthur He - Equity Research AnalystJay ...